Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 12INDUSTRY 4NIH 2

Study Type

Interventional 4

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 926Neoplasms 609Breast Neoplasms 604Colorectal Neoplasms 457Neoplasm Metastasis 394Ovarian Neoplasms 328Melanoma 312Prostatic Neoplasms 311Lung Neoplasms 294Multiple Myeloma 290Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 228Leukemia, Myeloid, Acute 220Triple Negative Breast Neoplasms 190Endometrial Neoplasms 190Carcinoma, Renal Cell 182Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 154Lymphoma, Follicular 148Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Interventions

VP-102 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Warts × 1 year × Clear all
NCT07457918 2026-05-05

COVE-4

Verrica Pharmaceuticals Inc.

Phase 3 Recruiting
600 enrolled

Warts

NCT07246590 2026-01-21

COVE-2

Verrica Pharmaceuticals Inc.

Phase 3 Recruiting
300 enrolled

Warts

NCT06958237 2025-09-08

Salicylic Acid Wart Patch for the Treatment of Common Warts and Plantar Warts

Langsteiner sp. z o.o.

Phase NA Completed
30 enrolled

Warts

NCT05889845 2025-09-05

Candin for the Treatment of Common Warts

Nielsen BioSciences, Inc.

Phase 3 Completed
330 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡